.png)
“The Great Eight”
Resident Presentation & Awards Program
Wednesday, June 18, 2025; 5pm - 8pm EDT
2 hours of live ACPE credit available
Hosted at University of Saint Joseph
1678 Asylum Ave, West Hartford, CT 06117
Member and Non-Members - $25
Incoming 2025-2026 CT PGY1 and PGY2 residents: Free
Registration Closes: June 6th
Payment Due: June 10th
REGISTER TODAY!ABOUT THE GREAT EIGHT
Join us for our annual, juried showcase of the work of Connecticut Pharmacy Residents. The Great Eight is an opportunity for Connecticut's Pharmacy Residents to present their research in front of clinical pharmacists and pharmacy administrators who are interested in the work that they have completed.
RETURNING FOR 2025
The Great Eight was introduced in 2012 to spotlight the work of CSHP's Resident Members. As of 2024, CSHP decided to open the Great Eight to all Residents in the state of Connecticut and the winning eight will receive a one year complimentary CSHP Resident Membership.
This event will offer 2 live ACPE credit hours for pharmacists and pharmacy technicians approved & accredited by the Hartford Healthcare as a provider of continuing pharmacy education for both pharmacists and pharmacy technicians.
ABSTRACTS
Submissions are due Wednesday May 7th, 2025
PARKING & DRECTIONS:
DON'T FORGET
UPDATE YOUR MEMBERSHIP profile/level to match your upcoming student or professional role.
Congratulations to the 2024 Great Eight Presenters!
1st Place: Sean Tan
- Title: Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies
- Objective: Assess the risk of bleeding among patients that receive CYP-interacting TKIs with DOACs compared to alternative, non-DOAC anticoagulation therapies
2nd Place: Emily Scurka- Title: Evaluation of HbA1c in Patients Followed by a Pharmacist and Pharmacy Liaison in an Endocrinology Clinic
- Objective: To evaluate whether patients in an endocrinology clinic who are followed by a pharmacist and a pharmacy liaison have grater HbA1c lowering compared to patients who are not followed by a pharmacist and pharmacy liaison.
3rd Place: Eleni Gaspar- Title: Impact of weekly versus twice weekly bortezomib on rates of peripheral neuropathy in combination with lenalidomide, dexamethasone and daratumumab
- Objective: Understand the impact of weekly bortezomib dosing on rates of peripheral neuropathy in patients with multiple myeloma receiving D-VRd
- Title: Impact of Therapeutic versus Sub-therapeutic Dosing of Etomidate in the Setting of Rapid Sequence Intubation
- Objective: Understand how etomidate works and how it is thought to cause adrenal insufficiency
- Title: Effect of Enteral Clonidine versus Guanfacine on Dexmedetomidine Withdrawal Compared to Dexmedetomidine Monotherapy in Critically Ill Patients
- Objective: Describe the difference in incidence of dexmedetomidine when using enteral clonidine compared to enteral guanfacine compared to dexmedetomidine monotherapy
- Title: Evaluation of Cost Savings Opportunity with the Use of an Alternative Factor VII Product within a Tertiary Academic Medical Center and Health System
- Objective: Describe the cost differences between factor VII formulations
- Title: Evaluation of biomarker testing practices for advanced and metastatic gastrointestinal cancers
- Objective: Examine real-world biomarker testing and targeted therapy compliance with national guideline recommendations in advanced and metastatic gastrointestinal cancers
- Title: Assessing real-world weight change in the treatment and prevention of HIV-1 with a cabotegravir-containing regimen
- Objective: Describe the real-world weight change in patients on a cabotegravir-containing regimen for treatment and prevention of HIV-1